Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

14.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A systematic review of forward simulation-based methods for point-source water pollution localization.

Journal of contaminant hydrology·2026
Same author

Identifying critical period of type 2 diabetes in Chinese population with leading molecules based on dynamic network biomarkers.

Scientific reports·2026
Same author

Simultaneous Determination of Levetiracetam, Sodium Valproate, and Olanzapine in Human Plasma by UPLC-MS/MS for Therapeutic Drug Monitoring.

Biomedical chromatography : BMC·2026
Same author

[Characteristics of the Pathogenic Bacteria Isolated from the Lower Respiratory Tract of the Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026
Same author

Identification of a novel major QTL and F-box candidate genes controlling seed dormancy in common wheat.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026
Same author

Venetoclax plus Idarubicin and cytarabine as frontline induction for newly diagnosed acute myeloid leukemia in young, fit adults: a real-world study.

Annals of hematology·2026

相关实验视频

Updated: May 2, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

12.6K

最近在CD5+扩散大B细胞淋巴瘤方面的进展.

Ningning Yue1, Qiqi Jin1, Cuicui Li1

  • 1Department of Hematology, Lanzhou University Second Hospital, Lanzhou, Gansu, 730030, China.

Annals of hematology
|August 28, 2024
PubMed
概括

CD5阳性扩散性大B细胞淋巴瘤 (DLBCL) 是一种罕见的,攻击性的非霍奇金淋巴瘤亚型.

关键词:
CD5+ DLBCLL 是一个CD5+ DLBCL高度的中枢神经系统复发新型疗法是一种新疗法.预后不好,预后不好.

更多相关视频

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.6K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.8K

相关实验视频

Last Updated: May 2, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

12.6K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.6K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.8K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤 (NHL).
  • CD5阳性 (CD5+) DLBCL代表了一个罕见而独特的亚组,占DLBCL病例的5-10%.
  • CD5+DLBCL与特定的临床和分子特征有关,包括年龄较大,女性性别,乳酸脱酶升高,ECOG表现不佳,晚期和更高的IPI得分.

研究的目的:

  • 审查CD5+DLBCL的临床特征,预后因素和治疗策略.
  • 探索导致CD5+DLBCL预后差的潜在机制.
  • 讨论CD5+DLBCL新出现的治疗方案.

主要方法:

  • 对CD5+DLBCL研究的文献综述.
  • 对CD5+DLBCL的临床和分子特征的分析.
  • 评估治疗结果和新的治疗方法.

主要成果:

  • CD5+DLBCL表现出不同的分子配置,通常表达MYC,BCL-2和MUM-1,属于ABC亚型.
  • 患有CD5+DLBCL的患者经常出现晚期疾病,中枢神经系统复发和骨髓干扰.
  • 标准的R-CHOP化疗在CD5+DLBCL中显示出有限的疗效,需要替代治疗策略.

结论:

  • CD5+DLBCL是一种异质和攻击性淋巴瘤亚型,具有独特的临床和生物特征.
  • R-CHOP的疗效低于最佳,DA-EPOCH-R的作用需要进一步研究.
  • 包括BTK抑制剂,BCL-2抑制剂,CXCR4抗剂和免疫疗法在内的新型疗法有望改善CD5+DLBCL的结果,这需要进一步的临床试验.